Atlas Trials

Celecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction Carcinoma

Clinical trial NCT00256321 · TERMINATED

Trial details

NCT number
NCT00256321
Sponsor
University of California, Irvine
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric CarcinomaGastroesophageal Junction Carcinoma
Start date
2004-10-01
Primary completion
2007-08-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.